Latest raise
$33.4M
Date raised
November 12, 2026
Round
Series A
InvestorsNorrsken VC, Singular
Websitewww.orakl-oncology.com
About Fanny Jaulin
a French TechBio company using AI and real patient biology to predict how cancer drugs will perform in clinical trials
- Who is Fanny Jaulin?
- Fanny Jaulin is listed as Co-founder of Orakl Oncology, a biotechnology company based in France.
- How much did Orakl Oncology raise?
- Orakl Oncology raised $33.4M in a Series A round on November 12, 2026 (1 days ago). Backed by Norrsken VC, Singular.
Get newly funded founders every week
A free weekly list of startups that just raised.